Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFβ signaling
Authors:
Open Access
- 1 July 2017
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (27) , 11466-11484
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 CA157779, R01 CA163820)
This publication has 68 references indexed in Scilit:
- TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cellsNature Immunology, 2012
- Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNAProceedings of the National Academy of Sciences, 2012
- Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Breast Cancer Research and Treatment, 2011
- Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor modelNature Biotechnology, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- 14-3-3ζ Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal TransitionCancer Cell, 2009
- MicroRNA expression profiling of human metastatic cancers identifies cancer gene targetsThe Journal of Pathology, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Combinatorial microRNA target predictionsNature Genetics, 2005
- Truncating mutations of RB1CC1 in human breast cancerNature Genetics, 2002